A detailed history of Manufacturers Life Insurance Company, The transactions in Humacyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 45,575 shares of HUMA stock, worth $232,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,575
Previous 34,919 30.52%
Holding current value
$232,432
Previous $167,000 47.9%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.11 - $9.46 $54,452 - $100,805
10,656 Added 30.52%
45,575 $247,000
Q2 2024

Aug 14, 2024

BUY
$2.87 - $9.1 $24,558 - $77,868
8,557 Added 32.46%
34,919 $167,000
Q1 2024

May 14, 2024

SELL
$2.57 - $4.84 $5,548 - $10,449
-2,159 Reduced 7.57%
26,362 $81,000
Q2 2023

Aug 11, 2023

BUY
$2.86 - $4.97 $38,046 - $66,115
13,303 Added 87.42%
28,521 $81,000
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.62 $30,740 - $55,089
15,218 New
15,218 $32,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $525M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.